Targeting early infection to prevent HIV-1 mucosal transmission

Nature

Volumn 464, Issue 7286, 2010, Pages 217-223

  Haase, Ashley T ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROBICIDE;

ANIMAL; HUMAN IMMUNODEFICIENCY VIRUS; INFECTIOUS DISEASE; PATHOLOGY; VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL MODEL; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS TRANSMISSION; VULNERABLE POPULATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; DISEASE MODELS, ANIMAL; HIV-1; HUMANS; IMMUNITY, MUCOSAL; MUCOUS MEMBRANE; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TIME FACTORS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77949409948     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature08757     Document Type: Review

References (99)

1. cell-free and cell-associated viral stocks. AIDS Res. Hum. Retroviruses 14 (Suppl. 1), S119-S123 (1998).
2. Weiler, A. M. et al. Genital ulcers facilitate rapid viral entry and dissemination following intravaginal inoculation with cell-associated simian immunodeficiency virus SIVmac239. J. Virol. 82, 4154-4158 (2008).
3. Miyake, A. et al. Rapid dissemination of a pathogenic simian/human immunodeficiency virus to systemic organs and active replication in lymphoid tissues following intrarectal infection. J. Gen. Virol. 87, 1311-1320 (2006).
4. Stahl-Hennig, C. et al. Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus. Science 285, 1261-1265 (1999).
5. Milush, J. M. et al. Rapid dissemination of SIV following oral inoculation. AIDS 18, 1-10 (2004).
6. 1 T cell depletion and viral replication in SIV infection. Science 280, 427-431 (1998).
7. 1 T cells in multiple tissues during acute SIV infection. Nature 434, 1093-1097 (2005).
8. 1 T cells. Nature 434, 1148-1152 (2005).
9. UNAIDS. 2008 Report on the global AIDS epidemic Æhttp://www.unaids. org/en/KnowledgeCentre/HIVData/GlobalReport/2008/2008-Global-report.aspæ (2008).
10. Fauci, A. S. 25 years of HIV. Nature 453, 289-290 (2008).
11. Cohen, J. Treatment and prevention exchange vows at international conference. Science 321, 902-903 (2008).
12. Bailey, R. C. et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 369, 643-656 (2007).
13. Auvert, B. et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2, e298 (2005).
14. Gray, R. H. et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 369, 657-666 (2007).
15. Rerks-Ngarm, S. et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 361, 2209-2220 (2009).
16. Karim, S. A. et al. Safety and effectiveness of vaginal microbicides BufferGel and 0.5% PRO 2000/5 gel for the prevention of HIV infection in women: Results of the HPTN 035 trial. Abstract 48LB (16th Conference on Retroviruses and Opportunistic Infections, 2009).
17. Buchbinder, S. P. et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomized, placebo-controlled, test-of-concept trial. Lancet 372, 1881-1893 (2008).
18. Check, E. Scientists rethink approach to HIV gels. Nature 446, 12 (2007).
19. Fauci, A. et al. HIV vaccine research: the way forward. Science 321, 530-532 (2008).
20. Quinn, T. C. & Overbaugh, J. HIV/AIDS in women: an expanding epidemic. Science 308, 1582-1583 (2005).
21. Haase, A. The slow infection caused by visna virus. Curr. Top. Microbiol. Immunol. 72, 101-156 (1975).
22. Miller, C. J. et al. Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus. J. Virol. 63, 4277-4284 (1989).
23. Fiebig, E. W. et al. Dynamics of HIV viremia and seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17, 1871-1879 (2003).
24. Miller, C. J. et al. Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J. Virol. 79, 9217-9227 (2005). Comprehensive tissue analysis of the pathogenesis of transmission and early infection in the nonhuman primate model of vaginal transmission of HIV-1.
25. Hu, J., Gardner, M. B. & Miller, C. J. Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J. Virol. 74, 6087-6095 (2000).
26. 1 T cells. Science 286, 1353-1357 (1999).
27. Reinhart, T. et al. Simian immunodeficiency virus burden in tissues and cellular compartments during clinical latency and AIDS. J. Infect. Dis. 176, 1198-1208 (1997).
28. 1 T cell demographics and dynamics in lymphatic tissues. Annu. Rev. Immunol. 17, 625-656 (1999).
29. Miller, C. M. & Shattock, R. J. Target cells in vaginal HIV transmission. Microbes Infect. 5, 59-67 (2003).
30. Christopher, D. P. et al. Brief but efficient: acute HIV infection and the sexual transmission of HIV. J. Infect. Dis. 189, 1785-1792 (2004).
31. Keele, B. F. et al. Low-dose rectal inoculation of rhesus macaques by SIV smE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. J. Exp. Med. 206, 1117-1134 (2009).
32. Sodora, D. L., Gettie, A., Miller, C. J. & Marx, P. A. Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with
33. Clayton, F., Snow, G., Reka, S. & Kotler, D. P. Selective depletion of rectal lamina propria rather than lymphoid aggregate CD4 lymphocytes in HIV infection. Clin. Exp. Immunol. 107, 288-292 (1997).
34. 1 T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 200, 761-770 (2004).
35. 1 T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200, 749-759 (2004).
36. 1 T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 77, 11708-11717 (2003).
37. Kotler, D. P., Gaetz, H. P., Lange, M., Klein, E. B. & Holt, P. R. Enteropathy associated with the acquired immunodeficiency syndrome. Ann. Intern. Med. 101, 421-428 (1984).
38. Heise, C., Miller, C. J., Lackner, A. & Dandekar, S. Primary acute simian immunodeficiency virus infection of intestinal lymphoid tissue is associated with gastrointestinal dysfunction. J. Infect. Dis. 169, 1116-1120 (1994).
39. Li, Q. et al. Simian immunodeficiency virus-induced intestinal cell apoptosis is the underlying mechanism of the regenerative enteropathy of early infection. J. Infect. Dis. 197, 420-429 (2008).
40. Estes, J. D. et al. Premature induction of an immunosuppressive T regulatory response in acute SIV infection. J. Infect. Dis. 193, 703-712 (2006).
41. 1 T-lymphocyte response to major immunodominant epitopes after vaginal exposure to SIV: too late and too little. J. Virol. 79, 9228-9235 (2005).
42. Brenchley, J. M. et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nature Med. 12, 1365-1371 (2006).
43. Estes, J. D. et al. Simian immunodeficiency virus-induced lymphatic tissue fibrosis is mediated by transforming growth factor b1-positive regulatory T cells and begins in early infection. J. Infect. Dis. 195, 551-561 (2007).
44. 1 T cells and limiting reconstitution of HIV-1 and SIV infections through damage to the secondary lymphoid organ niche. Semin. Immunol. 20, 181-186 (2008).
45. Wolinsky, S. et al. Selective transmission of human deficiency virus type 1 variants from mothers to infants. Science 255, 1134-1137 (1992).
46. Zhu, T. et al. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J. Virol. 70, 3098-3107 (1996).
47. Derdeyn, C. A. et al. Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science 303, 2019-2022 (2004). First description of the monophyletic nature of viruses transmitted heterosexually.
48. Keele, B. F. et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl Acad. Sci. USA 105, 7552-7557 (2008).
49. Salazar-Gonzalez, J. F. et al. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J. Exp. Med. 206, 1273-1289 (2009).
50. Norvell, M. K., Benrubi, G. I. & Thompson, R. J. Investigation of microtrauma after sexual intercourse. J. Reprod. Med. 269, 269-271 (1984).
51. Pudney, J., Quayle, A. J. & Anderson, D. J. Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol. Reprod. 73, 1253-1263 (2005).
52. O'Connor, D. M. A tissue basis for colposcopic findings. Obstet. Gynecol. Clin. North Am. 35, 565-582 (2008).
53. Li, Q. et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature 458, 1034-1038 (2009).
54. Celum, C. et al. Effect of acyclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomized, double-blind, placebo-controlled trial. Lancet 371, 2109-2119 (2008).
55. Watson-Jones, D. et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N. Engl. J. Med. 358, 1560-1571 (2008).
56. Zhu, J. et al. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nature Med. 15, 886-893 (2009).
57. Myer, L., Wright, T. C. Jr, Denny, L. & Kuhn, L. Nested case-control study of cervical mucosal lesions ectopy, and incident HIV infection among women in Cape Town, South Africa. Sex. Transm. Dis. 33, 683-687 (2006).
58. Miller, C. J., Alexander, N. J., Vogel, P., Anderson, J. & Marx, P. A. Mechanism of genital transmission of SIV: a hypothesis based on transmission studies and location of SIV in the genital tract of chronically infected female rhesus macaques. J. Med. Primatol. 21, 64-68 (1992).
59. Kell, P. D., Barton, S. E., Edmonds, D. K. & Boag, F. C. HIV infection in a patient with Meyer-Rokitansky-Kuster-Hauser syndrome. J. R. Soc. Med. 85, 706-707 (1992).
60. Padian, N. S. et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomisedcontrolled trial. Lancet 370, 251-261 (2007).
61. Berger, E. A., Murphy, P. M. & Farber, J. M. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17, 657-700 (1999).
62. Arthos, J. et al. HIV-1 envelope binds to and signals through integrin a4b7, the gut mucosal homing receptor for peripheral T cells. Nature Immunol.9, 301-309 (2008).
63. H-17 cells and are preferentially infected during acute SIV infection. Mucosal Immunol. 2, 439-449 (2009).
64. 1 T cells in transmission and acute simian immunodeficiency virus infection. Proc. Natl Acad. Sci. USA 101, 5640-5645 (2004).
65. Schacker, T. S. et al. Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. J. Infect. Dis. 183, 555-562 (2001).
66. Ma, Z., Lü, F. X., Torten, M. & Miller, C. J. The number and distribution of immune cells in the cervicovaginal mucosa remain constant throughout the menstrual cycle of rhesus macaques. Clin. Immunol. 100, 240-249 (2001).
67. Edwards, J. N. T. & Morris, H. B. Langerhans' cells and lymphocyte subsets in the female genital tract. Br. J. Obstet. Gynaecol. 92, 974-982 (1985).
68. Wira, C. R., Fahey, J. V., Sentman, C. L., Pioli, P. A. & Shen, L. Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol. Rev. 206, 306-335 (2005).
69. Wira, C. R., Grant-Tschudy, K. S. & Crane-Godreau, M. A. Epithelial cells in the female reproductive tract: a central role as sentinels of immune protection. Am. J. Reprod. Immunol. 53, 65-76 (2005).
70. Fahey, J. V. et al. Estradiol selectively regulates innate immune function by polarized human uterine epithelial cells in culture. Mucosal Immunol. 1, 317-325 (2008).
71. Dieu-nosjean, M. et al. Macrophage inflammatory protein 3a is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J. Exp. Med. 192, 705-717 (2000).
72. Cremel, M. et al. Characterization of CCL20 secretion by human epithelial vaginal cells: involvement in Langerhans cell precursor attraction. J. Leukoc. Biol. 78, 158-166 (2005).
73. Abel, K., Rocke, D. M., Chohan, B., Fritts, L. & Miller, C. J. Temporal and anatomic relationship between virus replication and cytokine gene expression after vaginal simian immunodeficiency virus infection. J. Virol. 79, 12164-12172 (2005).
74. Gray, R. H. et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 357, 1149-1153 (2001).
75. Wawer, M. J. et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J. Infect. Dis. 191, 1403-1409 (2005).
76. Vendrame, D., Sourisseau, M., Perrin, V., Schwartz, O. & Mamano, F. Partial inhibition of human immunodeficiency virus replication by type I interferons: Impact of cell-to-cell viral transfer. J. Virol. 83, 10527-10537 (2009).
77. Rudnicka, D. et al. Simultaneous cell-to-cell transmission of human immunodeficiency virus to multiple targets through polysynapses. J. Virol. 83, 6234-6246 (2009).
78. Wang, Y. et al. The toll-like receptor 7 (TLR7) agonist, imiquimod and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques. J. Virol. 79, 14355-14370 (2005).
79. Glavin, S. R. & Cohen, M. S. The role of sexually transmitted diseases in HIV transmission. Nature Rev. Microbiol. 2, 33-42 (2004).
80. Kaul, R. et al. The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission. J. Reprod. Immunol. 77, 32-40 (2008).
81. Haaland, R. E. et al. Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1. PLoS Pathog. 5, 1-13 (2009).
82. Robertson, S. A. Seminal plasma and male factor signalling in the female reproductive tract. Cell Tissue Res. 322, 43-52 (2005).
83. Robertson, S. A., Ingman, W. V., O'Leary, S., Sharkey, D. J. & Tremellen, K. P. Transforming growth factor b\a mediator of immune deviation in seminal plasma. J. Reprod. Immunol. 57, 109-128 (2002).
84. Berlier, W. et al. Seminal plasma promotes the attraction of Langerhans cells via the secretion of CCL20 by vaginal epithelial cells: involvement in the sexual transmission of HIV. Hum. Reprod. 21, 1135-1142 (2006).
85. Münch, J. et al. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 131, 1059-1071 (2007).
86. Li, Q. et al. Visualizing antigen-specific and infected cells in situ predicts outcomes in early viral infection. Science 323, 1726-1729 (2009).
87. 1 CTLs in delay of AIDS viral dissemination from mucosa. Blood 107, 3258-3264 (2006).
88. Genescà, M., Skinner, P. J., Bost, K. M., Lu, D. & Wang, Y. Protective attenuated lentivirus immunization induces SIV-specific T cells in the genital tract of rhesus monkeys. Mucosal Immunol. 1, 219-228 (2008).
89. Hansen, S. G. et al. Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nature Med. 15, 293-299 (2009).
90. Lifson, J. D. et al. Containment of simian immunodeficiency virus infection: Cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment. J. Virol. 74, 2584-2593 (2000).
91. Veazey, R. S. et al. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion. Nature 438, 99-102 (2005).
92. Lederman, M. M. et al. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5. Science 306, 485-487 (2004).
93. Cranage, M. et al. Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel. PLoS Med. 5, 1238-1250 (2008).
94. Zhu, T. et al. Persistence of extraordinarily low levels of genetically homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals. J. Virol. 77, 6108-6116 (2003).
95. 1-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV. J. Virol. 72, 10029-10035 (1998).
96. Ma, Z.-M., Abel, K., Rourke, T., Wang, Y. & Miller, C. J. A period of transient viremia and occult infection precedes persistent viremia and antiviral immune responses during multiple low-dose intravaginal simian immunodeficiency virus inoculations. J. Virol. 78, 14048-14052 (2004).
97. Trivedi, P. et al. Intrarectal transmission of simian immunodeficiency virus in rhesus macaques: selective amplification and host responses to transient or persistent viremia. J. Virol. 70, 6876-6883 (1996).
98. Li, Q. et al. Microarray analysis of lymphatic tissue reveals stage-specific, gene expression signatures in HIV-1 infection. J. Immunol. 183, 1975-1982 (2009).
99. Virgin, H. W. & Walker, B. D. Immunology and the elusive AIDS vaccine. Nature. (in the press).